tumor tissues; matched non-tumor tissues; xenograft tumors
MG63; HOS; U2OS; Saos-2; hFOB1.19
cell line-derived xenograft
ceRNA regulation (other); proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); glycolysis (promotes); metastasis (promotes); other pathway/process (promotes)
RT-qPCR; Clinical Sample Validation; Transfection; CCK8; Annexin V/PI Flow Cytometry; Transwell Assay; Western Blot; Bioinformatics Analysis; Luciferase Reporter Assay; RNA Pull-Down; RIP (RNA Immunoprecipitation); In Vivo Animal Model
circ-CDK14 expression was closely correlated with TNM stage and distant metastasis of OS tumors; the study suggests circ-CDK14 as a potential therapeutic target for OS.
circ-CDK14 is up-regulated in osteosarcoma tissues and cell lines. Functionally, circ-CDK14 supports OS malignant phenotypes including cell viability, migration, invasion, glycolysis and xenograft tumor growth while suppressing apoptosis. Mechanistically, circ-CDK14 acts as a miR-198 sponge to regulate E2F2 expression, forming a circ-CDK14/miR-198/E2F2 regulatory axis with potential therapeutic relevance.
0.7289
Silencing of circ-CDK14 suppresses osteosarcoma progression through the miR-198/E2F2 axis.
combined biological and clinical study